Epitomee Medical

Recent Finacing

Equity

Recent Raise

$8M

Epitomee Medical develops the orally administered, twice-daily shape‑shifting Epitomee Capsule that mechanically stimulates the stomach to induce early satiety and prolong gastric emptying; currently in Phase 2B clinical trials.

Founded 2005

Hefa, Israel

11-50

Publicly Traded

epitomeemedical.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Recent Investors

Financials

$8M

Total Raised

1

Funding round

2

Investors

Team

Upgrade to view the team

See the team members at Epitomee Medical.